Constant S, Sant'Angelo D, Pasqualini T, Taylor T, Levin D, Flavell R, Bottomly K
Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06510, USA.
J Immunol. 1995 May 15;154(10):4915-23.
Priming of naive CD4+ T cells to Ag requires an antigen-presenting cell (APC) that can take up the Ag and present peptide bound to MHC class II molecules. We have used both in vivo and in vitro approaches to demonstrate that the APC used to prime naive CD4+ T cells depends on the initial form in which an Ag is administered. Although Ag delivered as a peptide was presented most efficiently to CD4+ T cells by DC, these APC were poor at priming to a protein form of the same Ag. In contrast, the presence of B cells was a requisite for priming to protein Ag.
将初始CD4⁺ T细胞致敏于抗原需要一个能够摄取该抗原并呈递与II类主要组织相容性复合体(MHC)分子结合的肽段的抗原呈递细胞(APC)。我们已使用体内和体外方法来证明,用于初始CD4⁺ T细胞致敏的APC取决于抗原给药的初始形式。尽管以肽形式递送的抗原由树突状细胞(DC)最有效地呈递给CD4⁺ T细胞,但这些APC在将相同抗原的蛋白质形式致敏方面效果不佳。相反,B细胞的存在是将蛋白质抗原致敏的必要条件。